That number is the S$1.2 million of profit the company reported for shareholders, and the results-day headlines led with it [1]. It looks alarming, but it is misleading. It comes from an old ownership structure that ended on 1 July, the day after this period closed. It will not be there next time.

The number that matters is the margin, and it slipped. The business kept less profit from each dollar of sales than a year ago. Adjusted profit fell 17% to S$16.1 million, even though revenue rose 20%. The adjusted EBITDA margin dropped from 37.3% to 30.8%. That is what the market reacted to, and it is the number the whole valuation is built on.

The result came out on 13 August, after the market closed. The shares fell from S$0.805 to S$0.740 the next day, about 8%, then recovered over the following two sessions to S$0.775 by 17 August, back above the S$0.76 they listed at on 8 July. The half also carried S$5.4 million of one-off IPO and acquisition costs, against S$0.6 million a year earlier.

Prior Thesis Recap

We first wrote about Foundation Healthcare on 29 June, while the IPO was still open [2].

Our point then was simple. This is a good business, but it was coming to market through a structure that flatters its earnings just before listing. In FY2025 the group earned S$41.2 million, but only S$14.0 million reached shareholders. The doctors still owned 40% of most of their own practices, and took their share first. A pre-IPO deal called the Share Swap, done on 1 July, bought those doctors out and moved that profit to shareholders. We said the swap was struck cheaply and was good for new investors. We also said the real thing to watch was not the fast revenue growth, but what happened to margins once the practices sat inside the group. At the time we noted the IPO priced the stock at 21 to 25 times its pro forma earnings and 13 to 15 times pro forma EBITDA [2]; on the group's pro forma adjusted profit of S$51.4 million, the swap-neutral base we use below, that is about 20 to 24 times. This is the first result we can test that against.

New Financial Data

Here is the thing to understand about that S$1.2 million, because it explains this result and the next one.

Profit is counted before it is split between the group and the doctors who own minority stakes. The margins, the revenue growth, the adjusted profit, all of it is measured before that split. The Share Swap only changes the split. It takes the doctors’ share and gives it to shareholders. It does nothing to the profit the business makes in the first place.

So the S$16.1 million of adjusted profit the group earned this half is the same whether the doctors own 40% or nothing. This half ended on 30 June, one day before the swap. The old split still applied, so the doctors’ share, the non-controlling interests, took S$11.5 million of the S$12.7 million reported. And the S$5.4 million of acquisition and capital-raising costs, mostly the IPO, landed on shareholders too. That is how a business earning S$16 million of adjusted profit reports S$1.2 million to its owners.

Next half, the swap runs the same trick in reverse. The doctors’ share is gone, so shareholders keep almost all the profit, and the headline earnings will jump. That jump will look like a big recovery. It will not be one. It is just the swap.

The simplest way to hold this in your head: the swap changes the size of your slice, not the size of the pie. This half it made a decent pie look like a sliver. Next half it will make the pie look bigger than it grew. If you want to know how the business is really doing, ignore the slice and look at the pie. And the pie got thinner this half.

That is the real news. The business made less profit on each dollar of sales. Adjusted profit margin fell from 18.1% to 12.5%, so even with 20% more revenue, adjusted profit went down.

This matters because of what the market paid for.

Read more

On 11 August 2026 Jollibee led with a record. Net income to the parent (NIAT) of ₱3.40bn, up 5.7 percent on the year and up 130.5 percent on the first quarter, the best quarter the group has ever printed [1]. Revenue rose 10.7 percent to ₱85.9bn. System-wide sales grew 14.2 percent. The gross margin clawed back to 18.5 percent from 16.5 percent in Q1 and left June at 19.0 percent [1]. Same day, the board approved redeeming the ₱9bn Series B preferred (JFCPB) and trimmed parts of the full-year guidance [1][2].

The market liked it. Shares jumped about 5 percent to ₱156.00, above the ₱147.10 we anchored three weeks earlier [5]. Fair enough on the quarter. The half is another story: first-half NIAT was ₱4.87bn, down 13.3 percent year on year, operating income down 7.1 percent, net income down 16.7 percent [1]. So the record Q2 is a bounce off a weak, cost-pressured Q1, not a higher earnings base. And look under the operating line. Q2 income before tax actually fell 1.7 percent, to ₱4.84bn. NIAT rose anyway, because the tax rate dropped from 30.6 to 27.3 percent and the minority share fell 39 percent [3]. That gap, between the headline and what sits beneath it, is what this update is about.

Prior thesis recap

Our 22 July initiation made three claims.

1. The profit is almost entirely Philippine. Two-thirds of the stores are overseas, yet the international arm loses money at the net line while the home business pays for the build-out.

2. This is not the net-cash compounder some assume. At FY2025 the group carried about ₱86.5bn of debt against ₱34.9bn of cash, net debt near ₱52bn, plus ₱52.8bn of leases.

3. The “venue mirage.” A US listing of the arm can crystallise value but cannot sustain a US growth multiple, so its value is already explainable on Asian marks and needs no re-rating.

No price target. The sum-of-the-parts ran ₱145 to ₱225 on limited debt, ₱114 to ₱194 once the arm carries its fuller net debt. This quarter tests all three.

New financial data

The margin recovery is real, and we said as much. Pricing from April, plus sourcing and cost discipline, took the gross margin from 16.5 percent in Q1 to 18.5 percent in Q2, and June exited at 19.0 percent gross, 9.1 percent operating and 6.2 percent NIAT, the best run-rate of the year [1]. Group EBITDA rose 7.3 percent. No argument there.

It just was not broad. The EBITDA growth came from the Philippines, where EBITDA rose 12.8 percent. International EBITDA fell 0.4 percent, weighed down by ₱239m of transition costs as Smashburger and Yonghe King close stores and move to franchising [1]. Take out the home engine and the overseas arm grew its earnings by nothing this quarter.

Thesis check

Bear: “the profit is almost entirely Philippine.” Validated. The quarter says it in the segment lines. Philippine EBITDA up 12.8 percent, international EBITDA down. And yet international system-wide sales grew 25.4 percent, led by Highlands Coffee (+46.7 percent), Compose (+39.7 percent), Tim Ho Wan (+23.0 percent), Jollibee North America (+21.6 percent) and Milksha (+12.4 percent) [1]. Fast sales, no earnings. That is the shape we drew: a coffee-led arm that is real and growing and does not yet pay the group’s bottom line. The bull points at the 25 percent. The income statement still says Manila.

Bear: “not net cash; leverage is real and rising.” Validated, and worse. The balance sheet went the wrong way.

• Gross interest-bearing debt rose to ₱93.2bn at 30 June from ₱86.5bn; cash fell to ₱29.8bn from ₱34.9bn.

• Net debt ex-leases climbed to about ₱63.4bn from ₱51.6bn, up roughly ₱12bn in six months, near 1.5 times annualised EBITDA against about 1.2 at year-end [1][3].

The composition is the tell we flagged: senior notes fell ₱16bn to ₱36.6bn as JWPL redeemed the shorter 2020 tranche, but bank debt rose ₱21.9bn. “Partly refinanced with bank borrowings,” on the page. Financing interest rose 9.8 percent [3]. The record NIAT swallowed that bigger interest bill; it was not handed a smaller one.

Bear: the ₱9bn preferred redemption is another call on that same cash. Redeeming all nine million Series B preferred at their ₱1,000 price, about ₱9bn, on 14 October helps common holders a little in isolation: out goes a claim and a dividend that sit ahead of them [2]. But the balance sheet is already tighter than six months ago, and this is the same cash the change-of-control bond put we analysed at initiation could one day demand [4]. Pay it from cash and group cash drops toward ₱21bn. Pay it from debt and net debt heads toward ₱72bn. Either way, the liquidity we called committed gets more committed.

Bull: the coffee-led engine is real. On sales, not yet on profit. Highlands and Compose are compounding system-wide sales north of 40 percent. Jollibee Vietnam is the standout, same-store sales up 17.9 percent, store payback under four years. The group folded in Shabu All Day, a Korean brand under Jolli-K (172 stores acquired, 156 in the network at 30 June), about 5 percent of international sales [1]. The asset-light turn shows up where it matters: China’s franchise ratio is 62 percent, from 14 percent in 2016; Yonghe King is at 65 percent and aiming for 70; Canada added franchise development deals. This is the honest, non-venue route to a higher multiple we named as a trigger. It has not landed. International EBITDA is still flat-to-down, because the very restructuring that makes the arm asset-light costs money now. The winners win. The arm, as a whole, does not yet pay.

Flip trigger: “Compose and the coffee platform inflect to clear, sustained group-level profitability.” Not crossed. The one thing that would hurt us most is the overseas arm turning profitable at the net line. It went the other way. International EBITDA fell. We are watching for the quarter when “the profit is almost entirely Philippine” stops being true, and this half moved away from that, not toward it.

Bear: the venue mirage. No real update; the catalyst stayed quiet. Fifteen pages on record earnings, margins, capital-light growth and awards, and not one on the separation or the US listing, the centre of the whole bull case [1]. The 17-Q is barely louder: a routine subsidiary note tied to the planned spin-off, with no venue, no timing, no strategic-review update [3]. In January this was the headline. This quarter it is a footnote. One release is not cancellation, and we will not pretend it is. But it fits the drift we mapped, firm January plan to hedged June review, and it is not how a company markets a re-rating. A mirage stays a mirage while nobody points at it.

Risks revisited

Two risks moved.

1. Leverage moved up. Net debt rose about ₱12bn in six months, the preferred adds another ₱9bn, and the flexibility is thinner, so the change-of-control put, if a separation ever fired it, would hit a tighter balance sheet.

2. Execution moved down, a little: the margin recovery and the franchise discipline in China and North America show management can react to cost and will eat near-term charges to get asset-light.

Against that, the guidance cut. Full-year same-store growth trimmed to 3-4 percent, gross openings to 1,000-1,100 stores, operating-income growth to 10-15 percent, a quieter outlook than a year ago [1].

What to watch

Three things.

1. International EBITDA first: the quarter to wait for is the one where the Smashburger and Yonghe King costs roll off and the coffee winners are big enough to lift overseas earnings, not just sales. Until then the trigger holds.

2. The separation second: the next annual meeting, or any circular or notice to bondholders, answers the venue question, and its absence from results talk is itself worth logging.

3. The balance sheet third: the 14 October redemption, capex of ₱13-15bn, and whether net debt keeps climbing into the second half will tell us whether “committed liquidity” is easing or worsening. The 17 August briefing is the first chance for management to speak to any of it.

Bottom line

Call it a beat. We read it as a confirmation. Jollibee posted a real, home-led margin recovery and a record headline NIAT, and did it while the half was down double digits, overseas earnings went backwards, net debt rose about ₱12bn, and the US listing behind the bull case drew nothing but a footnote. None of that moves the initiation. The profit is still Philippine. The balance sheet is still levered, and more so. The venue mirage is quieter, not louder.

We stay non-directional, no price target. At ₱156 after the pop, the market sits in the lower half of our limited-debt band and above the fuller-debt one; the framework holds. JWPL’s own note balance fell as it redeemed a tranche, which helps the arm’s standalone equity a touch, but group net debt rose and a ₱9bn preferred call is booked, so the capital-structure-dependent range, with its wide gap between the two debt cases, matters more now, not less.

What would change our mind has not: an arm that turns durably profitable at the net line, or a separation document that gets more value, more cleanly, to a Manila holder than we expect.

Neither showed up this quarter. A record was set. It was set at home.

Data Integrity Notes

Q2 and 1H 2026 figures are taken from Jollibee’s 11 August 2026 press release and the accompanying SEC Form 17-Q; balance-sheet figures are from the unaudited consolidated statement of financial position as at 30 June 2026 in the 17-Q [1][3]. System-wide sales and same-store sales growth are management metrics and are not part of the audited financial statements. Net debt is our calculation (short-term debt plus current and non-current long-term debt plus senior debt securities, less cash and cash equivalents) and excludes IFRS-16 lease liabilities of ₱52.8bn. The ₱9bn preferred-redemption figure is nine million JFCPB shares at a ₱1,000 redemption price plus accrued dividends, per the 17-C redemption disclosure [2]. The share price of ₱156.00, up 5.05 percent on the day, is the PSE quote at the time of writing [5]; our initiation anchored ₱147.10 on 20 July 2026, so the stock has risen into the results and should be refreshed at publication. The results press release did not mention the US listing; the 17-Q carries a routine subsidiary disclosure tied to the planned international spin-off but no venue, timing, or strategic-review update [3]. This is our reading of the filings, not a company statement that the plan has changed.

References

[1] “The Jollibee Group Reports Record Q2 2026 Results, with Margin Recovery from Controlled Pricing and Record-High Quarterly Net Income Attributable to Equity Holders of the Parent Company,” Jollibee Foods Corporation press release (PSE 17-C, Form 4-31, C06118-2026), 11 August 2026.

[2] “Redemption of Series B Preferred Shares,” Jollibee Foods Corporation (PSE 17-C, Form 4-21, C06121-2026), 11 August 2026: 9,000,000 JFCPB shares at a ₱1,000 redemption price plus accrued dividends, less customary transfer costs, redemption date 14 October 2026, record date 30 September 2026, kept as treasury.

[3] Jollibee Foods Corporation SEC Form 17-Q for the quarter ended 30 June 2026 (PSE CR06002-2026), 11 August 2026: unaudited consolidated statement of financial position and statement of comprehensive income. Gross interest-bearing debt ₱93.2bn, cash ₱29.8bn, senior debt securities ₱36.6bn, long-term debt ₱40.6bn (current plus non-current), lease liabilities ₱52.8bn.

[4] The SEA Analyst, “Jollibee’s Global Arm Is Real. Its Wall Street Re-Rating Is a Mirage.” (initiation), 22 July 2026. https://www.theseaanalyst.com/p/jollibee-jfc-philippines-pse-stock-us-spin-off

[5] Jollibee Foods Corporation (PSE: JFC) share price of ₱156.00, up 5.05 percent on the day, the Philippine Stock Exchange quote as at 11 August 2026. https://www.pse.com.ph/company-information-JFC/

On the figures themselves the documents agree.

• Revenue for the six months to 30 June rose 24% to US$80.8 million.

• Cash EBITDA, the company’s measure of what the business generates after rent is actually paid and after corporate costs, rose 147% to US$10.6 million, lifting the margin from 6.6% to 13.1%.

• Free cash flow was US$3.2 million, against US$0.9 million a year earlier.

• The group ended the half with US$169.4 million of cash and no bank debt.

• It also reported a net loss of US$0.8 million, or a profit of US$0.1 million once one-off listing expenses are stripped out [6].

Two things came with the numbers.

1. The board intends to pay out 50% of net profit after tax from FY2027, the first dividend policy in the company’s history.

2. And the network reached 57 operational centres and 37,350 workstations, from 50 and 35,067 at the end of December, with 21 more centres described as committed.

The shares closed at S$0.630 on 6 August, before the release [13]. In the first session after it, on 7 August, they closed at S$0.640, up 1.6%, having traded between S$0.615 and S$0.660 on 1,282,200 shares against 455,100 the day before [1]. That leaves the stock 32% below the S$0.94 offer price of eleven weeks earlier.

What we said in May, and what we got wrong

Our 15 May initiation read the offer document [8] and declined to give a verdict on the price. The position we published was that both cases were true at once: a working operator with city-level density, and a structure carrying US$402.2 million of lease liabilities against US$40.4 million of equity, priced at roughly 130 times a maiden profit that leaned on a one-off gain. We wrote that the offer was “not a value entry point” and that it “asks the buyer to underwrite the next two years of expansion going broadly to plan”.

That piece named the dependencies but published no scorecard. It said that “every one of the bull points depends on the occupancy cycle staying friendly”, that “the maiden profit is flattered by a one-off”, and that “the raise itself adds 28 centres of fresh lease liability and the associated drag before those centres mature”. We are putting thresholds on those dependencies here, and adding one on how the expansion is paid for, as four tests of the franchise rather than of the price. This result is the first that can score any of them.

1. The occupancy test fails if group occupancy drops materially below 80%, or if the renewal rate reverses from the 72.0% it reached in FY2025.

2. Payback fails if new centres stretch well beyond the historical 16.4-month weighted average.

3. Profitability fails on the first post-listing result that shows an underlying loss once one-off items are stripped.

4. Funding fails on any sign that the expansion is being paid for by re-leveraging instead of by the IPO proceeds and internal cash.

Two things in that piece were wrong, and the second one we only found on re-reading the prospectus for this update.

The first is the call itself. We wrote that the post-listing share price would "partly reflect scarcity rather than fundamentals, which flatters it now and creates an overhang later". Instead the stock opened at S$0.835, closed its first day at S$0.775, 17.6% below the offer price, on 10.9 million shares [2], and has since traded as low as S$0.495 [1][3]. Scarcity supported nothing. The cohort was weak too, with all six companies that listed on SGX in 2026 trading flat or below their offer price as at 22 July [5], though that report gives no magnitudes, so we cannot say where JustCo's 32% ranks among them.

The second is the arithmetic underneath it. We described the float as 6.6% and said the cornerstone tranche would be released by a six-month moratorium in the fourth quarter. The offering was indeed 32,092,000 shares, or 6.56%. But the prospectus states plainly that “the Cornerstone Investors are not subject to any lock-up restrictions in respect of their shareholdings” [8]. Their 74,291,000 shares, a further 15.19%, could be sold from day one. The sellable pool at listing was therefore about 21.7% of the company, not 6.6%, and there is no cornerstone unlock ahead to price. We got that wrong in May and we are correcting it here.

The filings also show how thin the real demand was. DBS, as stabilising manager, bought 5,319,000 shares between listing and the close on 2 June, when it told the market that the over-allotment had been fully covered and the option would not be exercised [9]. That figure is 16.6% of the entire offering [10]. Through those first two weeks of trading, DBS bought back the equivalent of one share in six of the 32,092,000 Offering Shares. The price fell further once that stopped.

Where the growth came from

The revenue increase decomposes cleanly. Average occupied workstations rose about 12%, and revenue per occupied workstation rose 11%. Multiply the two and you have the 24%.

The extra workstations came from an acquisition. JustCo bought the remaining 51% of its Japan operations on 1 July 2025, so the first half of 2025 contains no consolidated Japan revenue and the first half of 2026 contains six months of it. Japan was an associate before that, so a share of its operating EBITDA does sit in the 1H2025 Cash EBITDA reconciliation, US$0.3 million of it, recorded in North Asia. That is the acquisition the review of performance names and the press release does not.

North Asia revenue went from US$15.3 million to US$27.1 million. That single segment accounts for 75% of the group’s entire revenue increase. On Cash EBITDA, North Asia went from US$1.1 million to US$5.4 million, or 68% of the group’s increase on the reported basis, and 73% if the equity-method share is stripped out of the 1H2025 base. Strip North Asia out and group revenue grew 7.7%.

Two operating metrics that JustCo published at the IPO are absent from all three documents it filed on 6 August: the membership renewal rate and the payback period on new centres [6][8]. For a business whose memberships run about 15 months against leases of three to fifteen years, those are the two numbers that say whether the model is working. Neither has been published since the prospectus.

Below the paywall: the half of the business with no acquisition in it more than doubled its Cash EBITDA. Rent took about 95% of the cash the business generated, leaving US$2.7 million. We score the result against four tests of the franchise, including the metric the company published at the IPO, and restate every valuation anchor at the 7 August close.

Read more

HL Global Enterprises reported its half year results on 3 August. Cash and bank balances rose again, to S$64.07 million from S$63.48 million at the year end. The shares are S$0.385 [1], which puts the market capitalisation at about S$37.1 million across the 96,334,254 shares in issue. The cash is therefore worth roughly 173% of the entire company, or 177% excluding the 2.4 million shares held in trust for a dormant option scheme, as the company does when it reports net asset value per share.

That gap has widened, not closed. When the Securities Investors Association (Singapore) put its questions to the board ahead of the April annual general meeting, it cited a market capitalisation of about S$45 million against S$63.5 million of cash. Four months later the cash is higher and the market value is lower.

The operating half was fine and beside the point. Revenue rose 12.2% to S$3.19 million on a better first half at the Cameron Highlands hotel. Net profit fell 10.0% to S$406,000: interest income on the cash dropped 30.7%, or S$252,000, as deposit rates came down, which was more than the S$237,000 improvement in the hospitality segment result. No dividend was recommended, in the same sentence the company has used in each of the last three interim filings.

What is worth reading is the board’s answer to SIAS. Asked directly whether share buybacks, special dividends or a broader strategic review had been formally evaluated, and on what timeline, the board replied: “While the Group maintains a positive cash position, it has not generated sufficient recurring profits in recent years to enable the declaration of dividends.” It added that it had considered various capital management and strategic options from time to time, and that “to date, no options have been identified that meet the Group’s strategic and financial criteria.”

Asked separately what drives the discount, the board listed the group’s size, limited trading liquidity, earnings profile, the concentration of its operating assets in a single hospitality location, and “the absence of dividend distributions in recent years as the Group conserves cash for operations and investment.” It named the absence of dividends as a cause of the discount, and then gave the absence of profits as the reason for the absence of dividends.

Both statements are accurate. The listed parent does carry accumulated losses of S$55.98 million and has no retained earnings to distribute from. But a shortage of distributable profits is a solvable problem rather than a permanent condition, and the mechanism is a capital reduction, which does not require distributable profits at all [2]. Two SGX-listed small caps used it in 2024, one to clear accumulated losses and one to hand back cash while loss-making [3][4]. HL Global used it itself in 1990, and the S$12.47 million special reserve still sitting on its balance sheet is what remains of that exercise. It has not proposed another since the 2017 disposals that created the cash pile, and it did not put a buyback mandate to the April meeting either.

Our position is unchanged. The market is not mispricing the cash. It is pricing the chance that anyone ever acts on it.

References

[1] HL Global Enterprises (SGX: AVX) share price and market data, at the 6 August 2026 close of S$0.385. https://stockanalysis.com/quote/sgx/AVX/

[2] Companies Act 1967 (Singapore), Division 3A of Part 4, sections 78A to 78K, on the reduction of share capital, including the court-approved route and the solvency-statement route. https://sso.agc.gov.sg/Act/CoA1967

[3] mDR Limited, “Circular to Shareholders dated 25 September 2024” in relation to a proposed capital reduction cancelling S$27,397,446 of accumulated losses against share capital, the company’s third such exercise after 2019 and 2021. https://links.sgx.com/1.0.0/corporate-announcements/OO9M37GKC7L839S3/819699_MDR_Capital_Reduction_Circular_25September2024.pdf

[4] Global Testing Corporation Limited, “Circular to Shareholders dated 5 April 2024” in relation to a proposed capital reduction and cash distribution of S$0.05 per share. https://links.sgx.com/1.0.0/corporate-announcements/HQ8T8ZBUH7YGHUYT/794834_GTC%20-%20Circular%20to%20Shareholders%20dated%205%20April%202024.pdf

Primary filings (SGX disclosures, no inline citation): HL Global Enterprises Limited, unaudited half year financial statements for the six months ended 30 June 2026 (3 August 2026); full year results for FY2025 (13 February 2026); half year results for 1H2025 and 1H2024; Annual Report 2025; Minutes of the Sixty-Third Annual General Meeting held on 21 April 2026 (19 May 2026); and Responses to Questions Received from the Securities Investors Association (Singapore) (15 April 2026).

IMPORTANT DISCLAIMERS

General Disclaimer: This article is published for informational and educational purposes only. It does not constitute financial advice, a recommendation, or a solicitation to buy, sell, or hold any securities. The views expressed are based on publicly available data from HL Global Enterprises’s SGX filings and publicly accessible market data, and may not reflect the most current developments.

Not Licensed Financial Advice: The author is not a licensed financial adviser, and this publication is not issued by a holder of a Capital Markets Services Licence under the Securities and Futures Act 2001 of Singapore. This content does not fall within the definition of “financial advisory service” under the Financial Advisers Act 2001 of Singapore. Readers in Singapore should note that this content is exempt from the requirements of the Financial Advisers Act pursuant to Regulation 34 of the Financial Advisers Regulations, as it is published in a generally available publication.

MAS Compliance Notice: In accordance with the Monetary Authority of Singapore’s guidelines, this publication does not take into account the specific investment objectives, financial situation, or particular needs of any individual. Before making any investment decision, you should consult a licensed financial adviser who can provide advice tailored to your personal circumstances. Past performance of any security discussed herein is not indicative of future results.

No Warranty: While the data and analysis have been prepared in good faith from public sources believed to be reliable, no representation or warranty, express or implied, is made as to the accuracy, completeness, or timeliness of the information. The author accepts no liability for any loss arising from the use of this material.

Disclosure: The author may or may not hold positions in the securities discussed. No compensation has been received from any company mentioned in this article.

Sunright’s own share price, meanwhile, has pulled back 15.6% from our 7 May 2026 publication close of S$0.895 to S$0.755 as of 30 May 2026. The operating asset improved. The price fell. The entry is better.

This note runs the data, checks the thesis breakers, refreshes the look-through valuation, and identifies what to watch next.

The numbers

The 9M PBT swing, from a RM8.4 million loss to a RM9.1 million profit, is not a marginal result. It is a full-cycle reversal on three quarters of data, covering the most operationally intensive months of the fiscal year. Revenue growth of 3% to RM161.3 million is incremental rather than transformative, but the cost-structure improvement did the heavier lifting: other expenses declined 15% (RM8.9 million lower year-on-year) from cost reductions in utilities, repairs and maintenance, and lower fair-value losses on investment securities. Employee expense fell 3% or RM1.8 million. Depreciation rose 8% as newly commissioned machinery and test equipment entered service.

The sequential read is softer: Q3 profit before tax of RM2.4 million was below Q2’s RM4.1 million. Management attribute this to a RM2.3 million net fair-value loss on investment securities (the equity portfolio KESM holds on its balance sheet) and the absence of a RM0.8 million impairment reversal that boosted Q2. Revenue was flat quarter-on-quarter (RM53.3 million versus RM54.9 million). The operating business has not deteriorated; the sequential dip is non-operating noise from the investment portfolio and one-time items.

Thesis breaker check

Five watchlist triggers were established at the time of the initiation.

Two consecutive flat or negative-growth revenue quarters. Q3 revenue grew 1% year-on-year (RM53.3 million versus RM52.8 million). Q2 grew 7% year-on-year. Neither quarter is flat or negative. ✓

Full-year FY2026 KESM revenue below RM215 million. Nine months produced RM161.3 million. Q4 requires RM53.7 million to clear the threshold, in line with Q3’s RM53.3 million and requiring no acceleration. ✓ On track.

FY2026 attributable net profit below RM4 million. Nine months produced RM6.6 million attributable. This threshold is cleared for the full year absent a material Q4 impairment. ✓

Employee/revenue ratio above 44%. Nine-month employee expense of RM61.9 million against RM161.3 million revenue gives 38.4%. This is well below the 44% structural-labour trigger. Operating leverage is running in the right direction. ✓

Total FY2026 dividend substantially above 6 sen. The interim dividend of 6.0 sen per share was paid on 28 October 2025. No additional dividend was declared in Q3. ✓ Consistent with reinvestment thesis.

None of the five triggers fired. All are tracking in the expected direction.

What management said for the first time

In prior quarterly announcements, KESM management described demand improvements in general terms: volume growth, customer mix, utilisation trends. In Q3 FY2026, the filing uses specific language in both the individual quarter and year-to-date discussions: “primarily driven by higher demand for the Group’s services in artificial intelligence (AI) related chips.” This is the first explicit AI attribution in a primary Bursa filing.

For the look-through thesis on Sunright, this matters. The initiation framed KESM’s AI exposure as probabilistic: a plausible demand driver validated externally by Aehr Test Systems’ USD 41 million hyperscale win, but not yet confirmed by the operating entity’s own language. That confirmation has now arrived. The RM28.4 million of outstanding capex commitments, layered on top of the RM39.5 million already deployed in 9M, reflect management’s confidence that the demand is durable enough to justify a capacity build-out ahead of the revenue.

The prospects section of the filing adds context: worldwide semiconductor revenue is expected to exceed USD 1.3 trillion in 2026, up 64% from 2025, driven by AI processing, data centre networking and power, and memory price inflation. AI semiconductors are projected to account for nearly 30% of total semiconductor revenue. KESM’s customer introductions are described as “closely aligned” with this cycle.

Look-through and valuation refresh

The headline compression since publication: S71 is down 15.6% while the operating entity improved. At publication, the core valuation tension was a 1.52x P/Attributable NAV on the SGX versus 0.58x P/Book on Bursa. That gap has narrowed modestly from the S71 side: the SGX multiple compressed to 1.28x as the price pulled back from near the 52-week high. The Bursa discount edged up marginally to 0.60x on slightly higher book value. The structure of the trade is unchanged: the KESM discount and the net cash floor are the same; the premium you pay for that optionality is lower.

The look-through decomposition at current prices: Sunright’s 48.41% KESM stake is worth S$31.9 million at Bursa market (versus S$30.7 million at publication). Subtract that from the S$92.7 million market cap and the implied value of Sunright’s Singapore parent entity (equipment manufacturing, management fees, and S$0.55/share in net cash) is S$60.8 million. The attributable book attributable to the non-KESM parent is roughly S$22 million. Implied ex-KESM P/Book: 2.74x, compressed from 3.6x at publication. The anomaly is smaller than it was; it persists.

The convergence-trade math: if KESM rerated to 1.0x book (MYR 7.97, +68% from MYR 4.74), Sunright’s KESM stake rises to S$53.6 million, a S$21.7 million uplift, or S$0.177 per Sunright share. At S$0.755, that delivers S$0.932, within range of the 52-week high. That scenario has not changed since the initiation; the book value it targets has grown, and the starting price is lower.

What to watch next

KESM Q4 FY2026 (estimated filing September 2026) is the confirmation quarter. If Q4 revenue holds at RM53 million or above, full-year FY2026 KESM revenue clears the RM215 million threshold. If PATMI holds near Q3’s quarterly rate, full-year attributable net profit will land around RM8 million, double the RM4 million minimum. The Q4 filing will also resolve whether a final dividend is declared for FY2026: any step-up above the 6 sen interim total would be the first dividend increase since FY2024.

Sunright FY2026 full-year results (estimated September–October 2026) will provide the consolidated picture: Sunright Singapore equipment revenue, intercompany management fees, and the attributable share of KESM’s full-year performance on one statement. That is the filing where the bull case (group revenue above S$90 million, attributable net profit above S$5 million) either clears or doesn’t.

Bottom line

KESM Q3 FY2026 is an operationally clean result: profitable through nine months, AI demand explicitly confirmed in primary filing language, capex tripled with capacity commitments signalling confidence in forward volume, and all five thesis breakers untriggered. S71 at S$0.755 offers the same structural optionality as the initiation, with the SGX/Bursa multiple gap intact and the net cash floor at S$0.55/share, at a meaningfully lower premium. The sequential Q3 dip was non-operating; the operating business is holding. The Q4 KESM result in September is the next binary.

Data integrity notes

Sunright’s latest published filing is the 1HFY2026 Condensed Interim Financial Statements (31 January 2026). The attributable NAV/share of S$0.588 used in the valuation table reflects that filing. KESM book value is updated to the Q3 FY2026 figure (30 April 2026). There is a one-quarter timing mismatch between the two book values; it is immaterial to the analysis.

FY2025 full-year KESM capex (RM16.0 million) is sourced from the KESM FY2025 Annual Report cash flow statement.

MYR/SGD conversion at 0.323 throughout, consistent with the published initiation. Exchange rate fluctuations affect the look-through valuation arithmetic; this rate has been stable in the RM3.09–3.10/S$1 range in the period since publication.

References

[1] KESM Industries Berhad, “Unaudited Third Quarterly Report on Consolidated Results for the Financial Quarter Ended 30 April 2026”, Bursa Malaysia filing, 28 May 2026.

[2] KESM Industries Berhad, “Unaudited Second Quarterly Report on Consolidated Results for the Financial Quarter Ended 31 January 2026”, Bursa Malaysia filing, 10 March 2026.

[3] Sunright Limited, “Condensed Interim Financial Statements and Dividend Announcement for the Half-Year Ended 31 January 2026”, SGX filing, 13 March 2026.

[4] Sunright (S71.SI) and KESM Industries Berhad (9334.KL), share price and market data via Yahoo Finance, retrieved 30 May 2026. https://finance.yahoo.com/quote/S71.SI / https://finance.yahoo.com/quote/9334.KL

IMPORTANT DISCLAIMERS

This article is published for informational and educational purposes only. It does not constitute financial or investment advice, a recommendation, or a solicitation to buy, sell, or hold any securities. The author is not a licensed financial adviser under the Financial Advisers Act 2001 of Singapore, nor a licensed adviser under the Capital Markets and Services Act 2007 of Malaysia. This content is exempt from the requirements of the Singapore Financial Advisers Act pursuant to Regulation 34 of the Financial Advisers Regulations, as it is published in a generally available publication. This publication does not take into account the specific investment objectives, financial situation, or particular needs of any individual. Before making any investment decision, readers should consult a licensed financial or investment adviser in their relevant jurisdiction. Past performance is not indicative of future results.

No Warranty: While the data and analysis have been prepared in good faith from public sources believed to be reliable, no representation or warranty, express or implied, is made as to the accuracy, completeness, or timeliness of the information. The author accepts no liability for any loss arising from the use of this material.

Disclosure: The author holds no position in the securities discussed and has not traded in them in the 30 days prior to publication, unless otherwise stated. This publication has received no compensation from any company discussed, or any related party.

That is the figure to anchor on. The reported profit decelerated 51.4% in FY2025 because the FY2024 comparable was inflated by fair-value gains; the same arithmetic now runs in reverse in 1HFY2026. What investors are paying for is the cash-generative operating engine, and that engine grew 13.9%: a real number, and a deceleration from FY2025’s reported 62.6% jump in core profit. That FY2025 figure, though, needs a closer look of its own — we return to it below.

So the first read of these results is a fork. Headline strong, underlying decelerating. Where you stand depends on whether you think the underlying number is depressed by the IPO/listing transition (S$1.2 million of cost still in the bridge) and the early phase of a room-ramp drag, or whether 13.9% is the new run-rate for a business that has now reached the gross-margin ceiling at roughly 71%.

The second thing the results did was reframe the strategy. The press release stated the goal of 10,000 rooms by 2030, the first public articulation of an explicit target, and announced a portfolio sale of seven freehold hospitality and living assets at a combined indicative S$218.5 million. Cushman & Wakefield ran the expression-of-interest exercise, bids closed 13 April 2026, and negotiations are reportedly underway [1][2]. Buyers can take vacant possession or sign a leaseback at a 3.5% gross yield. The properties cluster in three districts: three on River Valley Road, three in Balestier, one at 99 Rangoon Road. Two of the seven currently operate under management contracts rather than full ownership.

The sale is the strategically loaded piece of news in this period. If it executes, Coliwoo monetises roughly half of its S$428.2 million investment-property book and redeploys proceeds into master leases, management contracts, and selective acquisitions where mispricing or repositioning upside is available. Asset-light, capital-efficient, scalable. That model is well-understood. The Assembly Place (SGX:TAP), the only other listed Singapore co-living operator, has always run it. Coliwoo is converging on TAP’s model rather than running parallel to it.

What the numbers actually say

Read more

Those headlines sit alongside something more market-visible. DBS Group Research’s Chee Zheng Feng published a “buy” call with a 52-cent target price on 7 May 2026, five trading days before the result landed [1]. Volume on the day of the DBS publication ran 5.7 million shares against a three-month average of roughly 600,000 [2]. By the time the half-year numbers were released on 12 May, the shares had moved from 39 cents at the time of our April article, to a pre-DBS close of 39.5 cents on 6 May, before settling at 41.5 cents on results day [3].

The instinct is to declare the thesis strengthened. On a closer read, that conclusion overstates what the result actually shows.

Read more